UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 364

Sortiert nach

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

Value in health, 2014, Vol.17 (1), p.5-14

2014

Link zum Volltext

Verfügbarkeit prüfen

Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report

Value in health, 2014-03, Vol.17 (2), p.174-182

2014

Link zum Volltext

Verfügbarkeit prüfen

The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials

European heart journal, 2014-08, Vol.35 (30), p.2001-2009

2014

Link zum Volltext

Verfügbarkeit prüfen

Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

Value in health, 2012-09, Vol.15 (6), p.796-803

2012

Link zum Volltext

Verfügbarkeit prüfen

Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

Value in health, 2012-09, Vol.15 (6), p.843-850

2012

Link zum Volltext

Verfügbarkeit prüfen

Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4

Value in health, 2012-09, Vol.15 (6), p.821-827

2012

Link zum Volltext

Verfügbarkeit prüfen

Risk factors in adolescents as predictors of arterial hypertension in adults: Protocol for a systematic review

PloS one, 2021-08, Vol.16 (8), p.e0256596-e0256596

2021

Link zum Volltext

Verfügbarkeit prüfen

Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit–Risk Models: The Example of Rotavirus Vaccination in France

Clinical therapeutics, 2020-10, Vol.42 (10), p.1983-1991.e2

2020

Link zum Volltext

Verfügbarkeit prüfen

The impact of compliance with osteoporosis therapy on fracture rates in actual practice

Osteoporosis international, 2004-12, Vol.15 (12), p.1003-1008

2004

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore

Cancers, 2023-03, Vol.15 (6), p.1812

2023

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Restrictive Transfusion Practices on Hemodynamically Stable Critically Ill Children Without Heart Disease: A Secondary Analysis of the Age of Blood in Children in the PICU Trial

Pediatric critical care medicine, 2023-02, Vol.24 (2), p.84

2023

Link zum Volltext

Verfügbarkeit prüfen

Correction: Chua et al. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. Cancers 2023, 15, 1812

Cancers, 2023-09, Vol.15 (18), p.4658

2023

Link zum Volltext

Verfügbarkeit prüfen

The Barthel Index and modified Rankin Scale as prognostic tools for long-term outcomes after stroke: a qualitative review of the literature

Current medical research and opinion, 2007-07, Vol.23 (7), p.1627-1636

2007

Link zum Volltext

Verfügbarkeit prüfen

Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease

Orphanet journal of rare diseases, 2024-01, Vol.19 (1), p.14-14, Article 14

2024

Link zum Volltext

Verfügbarkeit prüfen

Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?

Value in health, 2010-12, Vol.13 (8), p.1056-1060

2010

Link zum Volltext

Verfügbarkeit prüfen

Best Practices: A Collection of Systematic Critical Reviews of Modeling Approaches in Specific Disease Areas

PharmacoEconomics, 2023-02, Vol.41 (2), p.119-121

Caro, J. Jaime

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacoeconomic analyses using discrete event simulation

PharmacoEconomics, 2005, Vol.23 (4), p.323-332

JAIME CARO, J

2005

Link zum Volltext

Verfügbarkeit prüfen

The efficiency frontier approach to economic evaluation of health-care interventions

Health economics, 2010-10, Vol.19 (10), p.1117-1127

2010

Link zum Volltext

Verfügbarkeit prüfen

How cost-effective are drugs and devices used in cardiology?

European heart journal, 2012-10, Vol.33 (19), p.2372-2373

Caro, Jaime J

2012

Link zum Volltext

Verfügbarkeit prüfen

Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S

Diabetes care, 2002-03, Vol.25 (3), p.476-481

2002

Link zum Volltext

Verfügbarkeit prüfen

Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics

PharmacoEconomics, 2016-07, Vol.34 (7), p.665-672

Caro, J. Jaime

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluating Montréal’s harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis

BMJ open, 2021-10, Vol.11 (10), p.e053191-e053191

2021

Link zum Volltext

Verfügbarkeit prüfen

Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–1

Medical decision making, 2012-09, Vol.32 (5), p.667-677

2012

Link zum Volltext

Verfügbarkeit prüfen

The Use of MCDA in HTA: Great Potential, but More Effort Needed

Value in health, 2018-04, Vol.21 (4), p.394-397

2018

Link zum Volltext

Verfügbarkeit prüfen

Let’s Make Sure We Are Doing Authorship Right

Value in health, 2020-07, Vol.23 (7), p.889-890

Caro, J. Jaime

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 364

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(326)
Mit Volltextzugriff
(318)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report

The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials

Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4

Risk factors in adolescents as predictors of arterial hypertension in adults: Protocol for a systematic review

Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit–Risk Models: The Example of Rotavirus Vaccination in France

The impact of compliance with osteoporosis therapy on fracture rates in actual practice

Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore

The Impact of Restrictive Transfusion Practices on Hemodynamically Stable Critically Ill Children Without Heart Disease: A Secondary Analysis of the Age of Blood in Children in the PICU Trial

Correction: Chua et al. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. Cancers 2023, 15, 1812

The Barthel Index and modified Rankin Scale as prognostic tools for long-term outcomes after stroke: a qualitative review of the literature

Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease

Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?

Best Practices: A Collection of Systematic Critical Reviews of Modeling Approaches in Specific Disease Areas

Pharmacoeconomic analyses using discrete event simulation

The efficiency frontier approach to economic evaluation of health-care interventions

How cost-effective are drugs and devices used in cardiology?

Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S

Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics

Evaluating Montréal’s harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis

Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–1

The Use of MCDA in HTA: Great Potential, but More Effort Needed

Let’s Make Sure We Are Doing Authorship Right

Suchergebnisse filtern